Himension Capital Singapore PTE. LTD. lifted its stake in shares of Veeva Systems Inc. (NYSE:VEEV – Free Report) by 28.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 17,281 shares of the technology company’s stock after acquiring an additional 3,864 shares during the quarter. Veeva Systems makes up approximately 0.3% of Himension Capital Singapore PTE. LTD.’s holdings, making the stock its 29th biggest holding. Himension Capital Singapore PTE. LTD.’s holdings in Veeva Systems were worth $3,633,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently modified their holdings of VEEV. MassMutual Private Wealth & Trust FSB increased its holdings in Veeva Systems by 72.5% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 119 shares of the technology company’s stock worth $25,000 after purchasing an additional 50 shares during the period. Centricity Wealth Management LLC purchased a new position in shares of Veeva Systems during the fourth quarter valued at $25,000. Smithfield Trust Co raised its holdings in shares of Veeva Systems by 145.5% in the fourth quarter. Smithfield Trust Co now owns 135 shares of the technology company’s stock valued at $27,000 after acquiring an additional 80 shares in the last quarter. Retirement Wealth Solutions LLC purchased a new stake in Veeva Systems in the fourth quarter worth about $31,000. Finally, Avion Wealth grew its holdings in Veeva Systems by 635.0% during the 4th quarter. Avion Wealth now owns 147 shares of the technology company’s stock worth $30,000 after acquiring an additional 127 shares in the last quarter. Institutional investors own 88.20% of the company’s stock.
Insider Buying and Selling at Veeva Systems
In other Veeva Systems news, SVP Jonathan Faddis sold 787 shares of the stock in a transaction dated Wednesday, April 2nd. The stock was sold at an average price of $226.20, for a total transaction of $178,019.40. Following the sale, the senior vice president now directly owns 8,668 shares of the company’s stock, valued at approximately $1,960,701.60. This trade represents a 8.32 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 10.50% of the company’s stock.
Veeva Systems Stock Down 3.6 %
Analysts Set New Price Targets
Several research firms have recently commented on VEEV. StockNews.com upgraded shares of Veeva Systems from a “hold” rating to a “buy” rating in a report on Monday, February 17th. The Goldman Sachs Group downgraded shares of Veeva Systems from a “buy” rating to a “sell” rating and reduced their price objective for the stock from $261.00 to $200.00 in a research note on Thursday, January 23rd. Scotiabank increased their target price on Veeva Systems from $240.00 to $245.00 and gave the company a “sector perform” rating in a research report on Thursday, March 6th. Robert W. Baird boosted their price target on Veeva Systems from $283.00 to $285.00 and gave the stock an “outperform” rating in a research report on Thursday, March 6th. Finally, Stephens reaffirmed an “overweight” rating and set a $280.00 price objective on shares of Veeva Systems in a research report on Thursday, March 6th. Two research analysts have rated the stock with a sell rating, eight have assigned a hold rating and sixteen have assigned a buy rating to the company. According to data from MarketBeat.com, Veeva Systems presently has a consensus rating of “Moderate Buy” and an average price target of $256.52.
View Our Latest Report on VEEV
About Veeva Systems
Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
Further Reading
- Five stocks we like better than Veeva Systems
- What Investors Need to Know to Beat the Market
- Conagra Stock Could Thrive as Tariffs Hit Other Sectors
- Investing In Automotive Stocks
- Grocery Costs and Tariffs Now Top of Mind in Everyday Conversations, New Survey Finds
- How to trade using analyst ratings
- Spotify Stock Eyes Double-Digit UpsideāIs Now the Time to Buy?
Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV – Free Report).
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.